| JERSX | MGLRX | JERSX / MGLRX | |
| Total Expense Ratio | 1.16 | 0.85 | 136% |
| Annual Report Gross Expense Ratio | 1.16 | 0.86 | 135% |
| Fund Existence | 18 years | 14 years | - |
| Gain YTD | 3.094 | 1.984 | 156% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 2500 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 312M | 2.22B | 14% |
| Annual Yield % from dividends | 2.90 | 3.33 | 87% |
| Returns for 1 year | 15.59 | 8.31 | 188% |
| Returns for 3 years | 13.53 | 7.79 | 174% |
| Returns for 5 years | 7.70 | 3.24 | 238% |
| Returns for 10 years | 72.73 | 52.14 | 140% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| FTDZX | 177.87 | 3.90 | +2.24% |
| Franklin Biotechnology Discovery Adv | |||
| MMMSX | 23.66 | 0.11 | +0.47% |
| Victory Integrity Small/Mid-Cap Value Mb | |||
| GEMCX | 26.24 | 0.02 | +0.08% |
| Goldman Sachs Emerging Markets Eq C | |||
| ASIRX | 12.56 | N/A | N/A |
| Alger Small Cap Growth Institutional R | |||
| JDCRX | 43.19 | -0.58 | -1.33% |
| Janus Henderson Forty R | |||